Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Neurosurg Focus. 2018 May;44(5):E16. doi: 10.3171/2018.1.FOCUS17802

TABLE 4.

Net economic benefit of ECTR

Variable DALY (3,1,0.04) DALY (0,0,0)
Gross economic benefit 8,386,905,542 14,978,888,306
ECTR economic benefit 1,006,428,665 1,797,466,597
Cost per ECTR* 2952
Total cost ECTR* 203,000,000
Net economic benefit of ECTR 803,428,665 1,594,466,597
Net economic benefit per patient
  100% 11,683 23,186
  90% 10,515 20,868
  80% 9347 18,549
  70% 8178 16,230

All values given in USD.

*

Reported by Medicare.

100%, 90%, 80%, and 70% surgical efficacy to avert DALYs.